Direct-Acting Antivirals Tied to Lower Risk of Liver Cancer in HCV
A new study found that direct-acting antiviral treatment is linked to decreased risk of liver cancer, liver-related death, and all-cause mortality.
Source: ConsultantLive - Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Source Type: news
More News: Cancer | Cancer & Oncology | Hepatitis | Hepatitis C | Internal Medicine | Liver | Study | Urology & Nephrology